RYVYX | UOPSX | RYVYX / UOPSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 25 years | 27 years | - |
Gain YTD | 35.090 | 33.796 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 15000 | 17% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 981M | 1.01B | 97% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 51.19 | 49.59 | 103% |
Returns for 3 years | 8.05 | -6.02 | -134% |
Returns for 5 years | 199.63 | 113.92 | 175% |
Returns for 10 years | 645.16 | 497.14 | 130% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FIBR | 87.09 | N/A | N/A |
iShares U.S. Fixed Inc Bal Rsk Sysmc ETF | |||
SCHE | 27.47 | -0.06 | -0.22% |
Schwab Emerging Markets Equity ETF™ | |||
ARKQ | 67.53 | -0.47 | -0.69% |
ARK Autonomous Technology&Robotics ETF | |||
RTH | 222.56 | -3.19 | -1.41% |
VanEck Retail ETF | |||
FTXH | 27.10 | -0.89 | -3.18% |
First Trust Nasdaq Pharmaceuticals ETF |